Aurinia Pharmaceuticals

AUPH

Insider trades and stock quote 2024-2026

All insider trades at Aurinia Pharmaceuticals

Subscribe RSS
Date Type Insider Position Ø-Price Volume
9/10/2026 Sell Robertson, Stephen P. Chief Legal Officer $16.0 $190,427
8/21/2026 Sell Robertson, Stephen P. Chief Legal Officer $17.0 $355,946
6/2/2026 Buy Tang, Kevin C. Chief Executive Officer $15.3 $3,147,756
6/1/2026 Buy Tang, Kevin C. Chief Executive Officer $15.3 $5,250,520
5/29/2026 Buy Tang, Kevin C. Chief Executive Officer $15.3 $4,056,951
3/3/2026 Buy Tang, Kevin C. Director $14.2 $2,619,438
3/2/2026 Buy Tang, Kevin C. Director $14.3 $2,842,833
2/27/2026 Buy Tang, Kevin C. Director $14.1 $7,226,535
8/5/2025 Buy Tang, Kevin C. Director $11.7 $2,336,000
8/4/2025 Buy Tang, Kevin C. Director $11.3 $1,134,000
8/1/2025 Buy Tang, Kevin C. Director $10.1 $10,120,000
8/1/2025 Sell Keenan, Greg Chief Medical Officer $10.5 $210,000
3/7/2025 Sell Keenan, Greg Chief Medical Officer $8.2 $68,350
3/4/2025 Buy Tang, Kevin C. Director $8.0 $5,953,304
3/4/2025 Sell Donley, Matthew Maxwell Chief Operating Officer $7.9 $467,209
3/4/2025 Sell Robertson, Stephen P. EVP, General Counsel $7.9 $456,247
3/4/2025 Sell Miller, Joseph M. Chief Financial Officer $7.9 $444,740
3/4/2025 Sell Greenleaf, Peter Chief Executive Officer $7.9 $1,306,380
3/3/2025 Buy Tang, Kevin C. Director $8.0 $3,625,473
3/3/2025 Sell Donley, Matthew Maxwell Chief Operating Officer $8.0 $527,216
3/3/2025 Sell Robertson, Stephen P. EVP, General Counsel $8.0 $518,976
3/3/2025 Sell Miller, Joseph M. Chief Financial Officer $8.0 $494,872
3/3/2025 Sell Keenan, Greg Chief Medical Officer $8.0 $97,912
3/3/2025 Sell Greenleaf, Peter Chief Executive Officer $8.0 $1,564,744
2/28/2025 Buy Tang, Kevin C. Director $7.8 $3,134,348
12/9/2024 Buy Tang, Kevin C. Director $9.1 $4,545,000
12/6/2024 Buy Tang, Kevin C. Director $9.0 $3,604,000
12/5/2024 Buy Tang, Kevin C. Director $8.9 $2,673,000
11/11/2024 Sell Smith, Karen L. Director $8.4 $44,182
11/11/2024 Sell Bailey, Jeffrey Allen Director $8.4 $38,416
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)